We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Hyatt Hotels
H
$16.9B
| $2.82M | 0.01% |
41,712
+1,007
| +2% | +$70.5K |
|
1452
Shenandoah Telecom
SHEN
$720M
| $2.81M | 0.01% |
63,621
+20,313
| +47% | +$867K |
|
1453
Outfront Media
OUT
$5.64B
| $2.8M | 0.01% |
157,033
+10,873
| +7% | +$207K |
|
|
EBIX
1454
DELISTED
Ebix Inc
EBIX
| $2.79M | 0.01% |
65,525
+11,586
| +21% | +$617K |
|
|
IMMU
1455
DELISTED
Immunomedics Inc
IMMU
| $2.79M | 0.01% |
195,374
+64,659
| +49% | +$1.28M |
|
1456
Tennant Co
TNC
$1.49B
| $2.77M | 0.01% |
53,234
+8,889
| +20% | +$543K |
|
1457
Novanta
NOVT
$5.45B
| $2.74M | 0.01% |
43,498
+13,922
| +47% | +$898K |
|
1458
Brown-Forman Class A
BF.A
$13.2B
| $2.74M | 0.01% |
57,692
-4,089
| -7% | -$195K |
|
1459
ePlus
PLUS
$2.47B
| $2.73M | 0.01% |
76,700
+12,992
| +20% | +$524K |
|
|
GBT
1460
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.73M | 0.01% |
66,481
+21,302
| +47% | +$798K |
|
|
MNTA
1461
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.73M | 0.01% |
247,115
+65,839
| +36% | +$916K |
|
1462
Sinclair Inc
SBGI
$1B
| $2.73M | 0.01% |
103,491
+27,485
| +36% | +$802K |
|
|
AL
1463
DELISTED
Air Lease Corp
AL
| $2.72M | 0.01% |
90,078
+1,825
| +2% | +$69.6K |
|
|
TBI
1464
Trueblue
TBI
$301M
| $2.72M | 0.01% |
122,232
+19,657
| +19% | +$471K |
|
|
ZNGA
1465
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.72M | 0.01% |
691,719
+11,010
| +2% | +$41.7K |
|
|
TSE
1466
DELISTED
Trinseo
TSE
| $2.7M | 0.01% |
59,062
+18,305
| +45% | +$995K |
|
1467
Atlantic Union Bankshares
AUB
$6.11B
| $2.7M | 0.01% |
95,588
+28,291
| +42% | +$953K |
|
1468
Interface
TILE
$2.04B
| $2.69M | 0.01% |
188,587
+28,941
| +18% | +$497K |
|
|
DNR
1469
DELISTED
Denbury Resources, Inc.
DNR
| $2.68M | 0.01% |
1,568,112
+99,506
| +7% | +$342K |
|
1470
Oil States International
OIS
$502M
| $2.68M | 0.01% |
187,629
+30,904
| +20% | +$711K |
|
|
PGRE
1471
DELISTED
Paramount Group
PGRE
| $2.67M | 0.01% |
212,955
+4,193
| +2% | +$59K |
|
|
TMHC
1472
DELISTED
Taylor Morrison
TMHC
| $2.67M | 0.01% |
168,160
+55,247
| +49% | +$902K |
|
|
ESV
1473
DELISTED
Ensco Rowan plc
ESV
| $2.67M | 0.01% |
187,223
+102,910
| +122% | +$2.65M |
|
|
CRAY
1474
DELISTED
Cray, Inc.
CRAY
| $2.66M | 0.01% |
123,146
+20,576
| +20% | +$465K |
|
1475
Invesco S&P 500 Equal Weight ETF
RSP
$99.3B
| $2.65M | 0.01% |
29,011
-613
| -2% | -$60.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.